Skip to content

Clinical trials

Bacteremia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bacteremia Country / region: United States Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20041
20054
20061
20072
20084
20093
20101
20115
20124
20134
20144
20159
20162
20175
20182
20192
20201
20212
20221
20232
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Terminated12
Unknown status3
Recruiting2
Active, not recruiting2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pittsburgh4
Duke University3
Accelerate Diagnostics, Inc.2
ContraFect2
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2
Henry Ford Health System2
Johns Hopkins University2
MicroPhage, Inc.2
National Institute of Allergy and Infectious Diseases (NIAID)2
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bacteremia71
Sepsis16
Staphylococcal Infections15
Endocarditis6
Infections5
Pneumonia5
Fungemia4
Gram-Positive Bacterial Infections3
HIV Infections3
Mycobacterium avium-intracellulare Infection3

Trials

Showing 26 to 50 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.